Navigation Links
Pregnant Women Who Use Nasal Decongestants During the First Trimester May Increase Their Babies’ Risks of Birth Defects; Parker Waichman LLP Is Evaluating Legal Claims
Date:7/25/2013

New York, New York (PRWEB) July 25, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that women who use nasal decongestants during the first trimester of their pregnancy may be raising the risk that their newborn will suffer from one or more rare birth defects, according to a new study written about in a July 23 Reuters report. Researchers at the Slone Epidemiology Center at Boston University found that phenylephrine, which is used in Sudafed, is associated with an eightfold increased risk of a heart deficiency called endocardial cushion defect when used in the first trimester. Acutrim, which contains phenylpropanolamine, was linked to an eightfold-higher risk of ear and stomach defects.

According to the Reuters report, this study claims that a threefold increased risk of limb reduction defects also is linked to first-trimester use of pseudophedrine, another Sudafed ingredient. In addition, imidazolines, which is used in nasal decongestant sprays and eye drops, was linked to a twofold increased risk of a defect that causes an abnormal connection between the trachea and the esophagus.

The study analyzed data from 12,700 infants born with non-chromosomal birth defects between 1993 and 2010, which was then compared to 7,600 infants without deformities, Reuters reported. One researcher told Reuters that he believes there is enough information now available that doctors should avoid prescribing nasal decongestants to pregnant women, although he concedes that this should be determined on an individual basis.

If you or a loved one took a nasal decongestant during your first trimester and gave birth to a child with non-chromosomal defects such as mentioned above, you have valuable legal rights. Please fill out our online form, or call 1-800-LAW-INFO (1-800-529-4636) to discuss your case with one of our nasal decongestant birth defects lawyers today.

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/nasal_decongestants/pregnant_defects/prweb10966976.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pregnancy Miracle Teaches Couples How to Get Pregnant with A Discount
2. Iodine in bread not enough for pregnant women
3. If You're Pregnant, Drinking Can Lead to Your Child's Death
4. Kim Kardashian – Plastic Surgery While Pregnant
5. The health and care of pregnant women and babies in Europe in 2010
6. Bowel Issues Affect 3 Out of 4 Pregnant Women
7. Fairhaven Health Launches New PregnancyPlus Natural Deodorant Designed Specifically for Pregnant Women
8. 72 percent of pregnant women experience constipation and other bowel problems
9. Announcing Bumpboosters Cookies: Delicious Nourishing Cookies for Pregnant Moms
10. For Pregnant Smokers, Vitamin C Might Help Babies Lungs
11. FDA Warns Pregnant Women About Migraine Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: